Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
4DMedical Ltd ( (AU:4DX) ) has provided an update.
4DMedical Limited has applied to the ASX for quotation of a total of 6,136,176 new fully paid ordinary shares, issued on various dates between 6 and 16 January 2026, following the exercise or conversion of options or other convertible securities. The additional quoted shares modestly expand the company’s free float and capital base, potentially improving liquidity in 4DMedical’s stock and providing further financial flexibility to support its growth in respiratory imaging technologies.
The most recent analyst rating on (AU:4DX) stock is a Hold with a A$4.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Limited (ASX: 4DX) is an Australian-listed medical technology company specialising in advanced respiratory imaging and software solutions for lung function analysis, serving healthcare providers and institutions focused on pulmonary diagnostics and respiratory care.
Average Trading Volume: 4,580,187
Technical Sentiment Signal: Buy
Current Market Cap: A$2.3B
For detailed information about 4DX stock, go to TipRanks’ Stock Analysis page.